EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrated hearing and genetic screening for neonatal deafness in a resource-limited region: insights from Qingyuan, China

Qin She, Hui-Lin Ou, Er-Fang Tang, Wei Huang, Wei-He Tan, Mu-Lan Zeng, Xiu-Feng Pan, Chen-Bing Liu

Frontiers in Genetics · 30.06.2026 · 17

DOI: 10.3389/fgene.2026.1873535 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Genetics, online erschienen am 30.06.2026. Verfasst von Qin She und 7 weiteren Autor:innen. Beteiligte Einrichtung: Prenatal Diagnostic Center, The Affiliated Qingyuan Hospital (Qingyuan People's Hospital), Guangzhou Medical University, Qingyuan, Guangdong, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aimed to delineate the prevalence and mutation spectrum of deafness-associated genes among newborns in a resource-limited region of China, and to assess the diagnostic yield of combined hearing and genetic screening.

Methods

From May 2017 to May 2023, 22,819 newborns underwent concurrent hearing screening and genetic screening for deafness-associated mutations using 9-variant or 23-variant microarrays targeting GJB2, SLC26A4, GJB3, and mitochondrial 12SrRNA. Whole-exome sequencing was performed in selected cases with inconclusive results. All infants were followed until 2.5 years of age.

Results

Hearing screening confirmed hearing loss in 25 infants (0.11%). Genetic screening identified 994 (4.36%) mutation carriers, predominantly GJB2 (3.31%) and SLC26A4 (0.78%). Among 351 GJB2 109G>A heterozygotes, all had normal hearing at 2.5 years. Among 43 homozygotes, 7 (16.28%) had congenital deafness; the rest remained normal. All 42 mitochondrial mutation carriers remained deafness-free after preventive education. The 23-variant panel detected 24.73% positive cases (225-fold vs. hearing alone). WES resolved 80% of ambiguous cases.

Conclusion

GJB2 and SLC26A4 are the predominant deafness genes in this region. Combined screening identifies distinct risk groups, heterozygotes for reproductive counselling, mitochondrial carriers for prevention, and homozygotes for early intervention. Long-term follow-up of normal-hearing homozygotes showed low short-term delayed-onset risk.

Schlagwörter

Stichwörter der Autor:innen

GJB2 gene mutationsgenetic screening for deafnessneonatal hearing screeningresource-limited regionswhole exome sequencing (WES)

Autor:innen und Institutionen

  • Prenatal Diagnostic Center, The Affiliated Qingyuan Hospital (Qingyuan People's Hospital), Guangzhou Medical University, Qingyuan, Guangdong, China.
  • Department of Obstetrics and Gynecology, Kaifeng Maternal and Child Health Hospital, Kaifeng, Henan, China.

Zitieren

APA

She, Q., Ou, H. L., Tang, E. F., Huang, W., Tan, W. H., Zeng, M. L., Pan, X. F., & Liu, C. B. (2026). Integrated hearing and genetic screening for neonatal deafness in a resource-limited region: insights from Qingyuan, China. Frontiers in Genetics, 17. https://doi.org/10.3389/fgene.2026.1873535

Vancouver

She Q, Ou HL, Tang EF, Huang W, Tan WH, Zeng ML, et al. Integrated hearing and genetic screening for neonatal deafness in a resource-limited region: insights from Qingyuan, China. Frontiers in Genetics. 2026;17. doi:10.3389/fgene.2026.1873535

BibTeX
@article{She2026,
  author = {She, Qin and Ou, Hui-Lin and Tang, Er-Fang and Huang, Wei and Tan, Wei-He and Zeng, Mu-Lan and Pan, Xiu-Feng and Liu, Chen-Bing},
  title = {Integrated hearing and genetic screening for neonatal deafness in a resource-limited region: insights from Qingyuan, China},
  journal = {Frontiers in Genetics},
  year = {2026},
  volume = {17},
  doi = {10.3389/fgene.2026.1873535}
}
Kostenlos starten →